News Brief: Know Labs Announces Laboratory Comparison Tests of Its UBAND Non-Invasive Blood Glucose Technology and Abbott Labs FreeStyle Libre

Know Labs, Inc. (OTCQB:KNWN), a provider of identification, authentication and diagnostic solutions, released today a video overview of comparison tests of the Company’s invention of its UBAND™ wearable to detect blood glucose non-invasively and Abbott Labs FreeStyle Libre. In the video Company CEO Phil Bosua discusses the breakthrough and highlights a comparison of the Know Labs UBAND Bio-RFID™ technology with an industry-leading continuous glucose monitor from Abbott Laboratories (NYSE:ABT). For more information visit www.knowlabs.co 

This episode is brought to you via Stock Wave - a production company that provides audio & video services to variety of clients. Stock Wave may have been compensated for the production of this audio service.

In trading, there can be no assurance that any prior successes or past results as to income earnings can be used as an indication of future success or results. Audio/video services by Stock Wave are for informational purposes only and do not purport to be a complete study of the featured company or other companies mentioned. Information used and statements of fact have been obtained from the featured company and other sources, but not verified nor guaranteed by Stock Wave, as to completeness or accuracy.

Listeners are advised to use caution and seek the advice of qualified professionals before acting on any information provided by Stock Wave’s audio/video services. Listeners are also advised to perform their own due diligence when it comes to making investment decisions.